Saturday Sep 06, 2025
Friday, 5 September 2025 00:06 - - {{hitsCtrl.values.hits}}
![]() |
Dr. Sanjeewa Rajapakse |
Melsta Hospitals Ragama has announced the appointment of Dr. Sanjeewa Rajapakse to its Board of Directors. Dr. Rajapakse is a highly accomplished Consultant Cardiologist with nearly 25 years of medical experience, bringing not only clinical excellence but also leadership, strategic insight, and industry foresight to guide the hospital as it continues to deliver affordable, international-standard healthcare to the public.
Dr. Rajapakse holds a Doctor of Medicine (MD) from the Postgraduate Institute of Medicine, University of Colombo, with advanced training in General and Interventional Cardiology at the Dorset Heart Centre, UK. A distinguished graduate of the Faculty of Medicine, University of Ruhuna (MBBS, Upper Second Class with Distinction in Pediatrics, All-Island Rank 01), he is affiliated with prestigious professional bodies including the Royal College of Physicians (UK), European Heart Association, American College of Cardiology, and is a Fellow of the Society of Coronary Angiography and Intervention (USA). He currently serves as Consultant Cardiologist at Colombo North Teaching Hospital, Ragama, with expertise spanning Percutaneous Coronary Interventions, Adult Structural Heart Disease, Echocardiography, CT Coronary Angiogram, and Permanent Pacing.
Commenting on the appointment, Melsta Hospitals Ragama Chairman Royle Jansz said, “We are delighted to welcome Dr. Sanjeewa Rajapakse to our board. Beyond his exceptional clinical expertise, he brings visionary leadership, deep industry knowledge, and strategic insight. His guidance will strengthen our ability to expand services, enhance patient care, and continue positioning Melsta Hospitals as a benchmark for international-standard healthcare in Sri Lanka. We look forward to his contributions across clinical, operational, and strategic dimensions as we shape the future of the hospital.”
Dr. Rajapakse commenting on his appointment stated, “I am honoured to join one of the most forward-thinking director boards in Sri Lanka’s healthcare sector, backed by the strength of Melstacorp, one of the nation’s most reputed and well-established conglomerates. I look forward to contributing to the best of my capacity as we continue to advance affordable, international-standard healthcare for our communities.”
Melsta Hospitals Ragama, part of Melsta Health Ltd., and the wider Melstacorp PLC group, is a modern healthcare facility in the North Colombo/Gampaha district providing accessible, high-quality care. The hospital has quickly become a benchmark in the healthcare sector, offering state-of-the-art infrastructure, comprehensive diagnostic services, and specialised centres including Gastrointestinal, Urology, and Kidney Transplant programs. Operating under a robust Integrated Management System spanning ISO 9001, ISO 22000, ISO 14001, and ISO 45001, the hospital aligns day-to-day operations with international standards for quality, safety, and occupational health.
Melsta Hospitals is also advancing a structured journey toward JCI accreditation, reflecting its commitment to international-quality healthcare and patient safety standards. Supported by the AAA (lka)-rated Melstacorp PLC, the hospital is progressing initiatives to serve domestic and regional patients while delivering care that is affordable and easily accessible.
The hospital’s growth and ambition are guided by a distinguished Board of Directors, whose expertise spans healthcare leadership, corporate governance, and strategic development. The Board comprises Melsta Hospitals Ragama Chairman/Melstacorp PLC Deputy Chairman C.R. Jansz, Melsta Hospitals Ragama Director/Melstacorp Executive Chairman Hasitha Jayawardena, Melsta Hospitals Ragama Executive Director/CEO and Melsta Health Director/CEO Dr. K. Thiyagarajah Iraivan, and Melsta Hospitals Ragama Director M.N. Sampath Perera. The addition of Dr. Rajapakse strengthens this leadership team, bringing clinical vision and strategic guidance as the hospital continues its trajectory of growth and excellence.